Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Promore Pharma

Less than 1K followers
All
Press releases
ShowingAll content types
Regulatory press release1/14/2025, 4:38 PM

PMD Device Solutions' Bankruptcy Application Granted

Promore Pharma
Regulatory press release12/22/2024, 3:03 PM

PMD Device Solutions AB (publ) has Filed for Bankruptcy

Promore Pharma
Regulatory press release11/29/2024, 7:00 AM

Q3 Interim report July - September 2024

Promore Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release11/26/2024, 7:30 AM

PMD Device Solutions Completes Sale of Coala Life Monitor to Inventor Magnus Sörlander

Promore Pharma
Regulatory press release11/20/2024, 12:12 PM

PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report

Promore Pharma
Regulatory press release11/5/2024, 3:37 PM

PMDS announces last day of trading in BTA

Promore Pharma
Regulatory press release10/29/2024, 1:13 PM

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

Promore Pharma
Regulatory press release10/29/2024, 1:10 PM

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

Promore Pharma
Regulatory press release10/14/2024, 5:00 AM

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

Promore Pharma
Regulatory press release10/11/2024, 7:22 AM

PMDS’ Largest Shareholder Requests EGM to Appoint New Non-Executive Directors Amid Management Changes

Promore Pharma
Regulatory press release10/7/2024, 3:01 PM

PMD Device Solutions Restructures to Focus Resources on Global Sales Expansion

Promore Pharma
Regulatory press release9/26/2024, 11:34 AM

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

Promore Pharma
Press release9/17/2024, 11:39 AM

PMD Device Solutions’ RespiraSense Technology Demonstrates Capability in Predicting 7-Day Mortality

Promore Pharma
Regulatory press release9/12/2024, 2:55 PM

PMDS carries out a directed issue of shares to underwriter in the completed rights issue

Promore Pharma
Press release9/11/2024, 6:04 AM

PMDS Secures New Contract in the Western United States, Accelerating Path to Profitability

Promore Pharma
Press release9/5/2024, 5:18 PM

PMD Device Solutions Secures Significant Sales Contract, Setting the Stage for Significant Growth in the US

Promore Pharma
Regulatory press release9/4/2024, 7:44 PM

PMDS announces outcome of rights issue

Promore Pharma
Press release8/27/2024, 8:34 AM

Redeye: PMD Solutions - PMD is approaching a cash-positive run rate before 2025

Promore Pharma
Regulatory press release8/22/2024, 6:00 AM

Q2 Interim report April-June 2024

Promore Pharma
Regulatory press release8/16/2024, 9:15 PM

PMDS publishes information memorandum in connection with the forthcoming rights issue

Promore Pharma
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.